Prenatal Testing: The Importance of Early Preeclampsia and Genetic Screening in Pregnancy

Early preeclampsia and genetic screening in pregnancy can identify conditions that may increase risk for fetal and maternal complications. Insights from these screenings can help your patients better prepare for the future.In our webinar, you'll learn how early preeclampsia screening and the latest developments in cell-free DNA (cfDNA) noninvasive prenatal testing (NIPT) can help you improve maternal and perinatal outcomes.

On-Demand Webinar: Systemic Mastocytosis - Insights Into A Rare Blood Disorder

Presented by guest speaker Dr. Alejandro Gru, MD, Professor of Dermatology and Director of Dermapathology at Columbia University’s Irving Medical Center, this webinar provides information about systemic mastocytosis, a rare blood disorder where abnormal mast cells (white blood cells) build up in different parts of the human body, resulting in a variety of symptoms. It is estimated that over 32,000 United States citizens could be living with this disease, and this webinar profiles what causes systemic mastocytosis, how this condition affects patients, how systemic mastocytosis can be detected and how are patients being treated for this disease.

Continuing Education Series Features: Is it a blast or a lymphocyte?

Patient-based Real-Time Quality Control: More Quality at Less Cost

Patient-based Real-Time Quality Control: More Quality at Less Cost

The Cardiorenal Connection: Highlighting Cardiovascular Risk in Chronic Kidney Disease

Operationalizing Innovative Biomarkers to Support Evolving Therapeutic and Diagnostic Landscape for Neurodegenerative Diseases

On-demand webinar: Developing predictive cancer models and more persistent CAR T-cell therapies through enhanced metabolic fitness

Molecular Tumor Board: 82-year-old female with high grade ovarian serous adenocarcinoma and BRCA1 F709fs mutation

An 82-year-old with advanced high-grade serous ovarian cancer and a BRCA1 mutation highlights the importance of somatic and germline testing to guide therapy and using PARP inhibitors for maintenance. Join our Molecular Tumor Board to explore treatment strategies and the impact of reversion mutations on resistance management.

Molecular Tumor Board: 58-year-old male with breast carcinoma and BRCA2 R3128* mutation

Though less common than in women, understanding male breast cancer and symptoms can lead to earlier detection and improved outcomes.

Clinical considerations of drug testing in the primary care setting

Drug testing plays a critical role in monitoring patients who are prescribed controlled substances, including opioid pain medications, anti-anxiety medications, stimulants and drugs to treat substance use disorder. Testing choices have expanded in recent years and choosing the most appropriate drug testing involves considering many factors. Join Labcorp’s toxicology experts to gain insights into the fundamentals of clinical drug testing to help inform patient treatment decisions.